Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study
Version 2 2024-06-02, 23:22Version 2 2024-06-02, 23:22
Version 1 2023-11-02, 05:13Version 1 2023-11-02, 05:13
journal contribution
posted on 2024-06-02, 23:22authored byHM Prince, D Rischin, GC Toner, JF Seymour, D Blakey, Priscilla GatesPriscilla Gates, S Eerhard, P Chapple, M Quinn, M Brettell, S Juneja, M Wolf, EH Januszewicz, G Richardson, J Scarlett, P Briggs
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study